Fingers crossed. They've had plenty of time to do DD. I'm sure Missling has been making connections and shopping us around for in-licensing and partnership deals. It's good for leverage. There's no loyalty when it comes to business. There's no way we are sitting around waiting for Biogen to make up their mind. No exclusive agreements here.
Being second gets you nothing. Make a serious offer and close the deal cuz we have a line waiting to take your place.
Where else can you find our potential and 3 trials about to start? nowhere
Market Data 
Markets 
AI
